Skip to content
MarketScale
‹ Back to IndustriesHealthcare

AI-Powered Care Navigation Reduces Healthcare Spend and Improves Patient Access

This episode of I Don't Care explores how Embold Health's AI-powered care navigation platform helps employers reduce healthcare costs by directing employees to high-performing, clinically validated providers. Host Kevin Stevenson and guest Dr. Daniel Stein discuss how generative AI, natural language processing, and a dataset of over 230 million medical records are used to replicate physician triage logic. Employers using the platform have seen annual care cost reductions of 3–5% without sacrificing care quality.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Ai in HealthcareDaniel SteinEmbold HealthHealthcare Navigation
Share

Key takeaways

01

Embold Health uses AI and 230 million+ medical records to match patients with top-performing providers, reducing employer healthcare costs by 3–5% annually.

02

The platform replicates physician triage logic using generative AI and natural language processing, making care navigation accessible without requiring medical expertise.

03

Embold's AI is bias-tested and built on Microsoft's responsible AI standards, prioritizing transparency and outcome-driven recommendations.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers (where provider quality and convenience are comparable).” This strategy enables companies to save thousands of dollars per patient annually while enhancing the quality of care. As generative AI transforms industries, the question is no longer whether to adopt it, but how to do so ethically and effectively in healthcare.

Can AI help people find the right doctor—not just any doctor—while saving employers money and simplifying decision-making?

This episode of I Don’t Care, hosted by Dr. Kevin Stevenson, features Dr. Daniel Stein, internal medicine physician and CEO of Embold Health. Together, they unpack how Embold’s AI-powered platform is redefining care navigation through clinical logic, natural language processing, and massive datasets, guiding patients to high-performing providers matched to their needs and preferences.

Key Highlights from the Conversation:

  • AI That Guides, Not Replaces: Embold uses generative AI to replicate a physician’s triage logic and connect patients with the most appropriate, clinically validated provider, without needing a medical degree to navigate the platform.
  • Cost Savings Through Quality: Employers using Embold’s navigation tools have seen care costs drop 3–5% annually by steering employees to top providers, without relying on pricing alone.
  • Guardrails and Transparency: Backed by Microsoft’s responsible AI standards, Embold’s platform is bias-tested and built on a foundation of over 230 million medical records, ensuring recommendations prioritize outcomes and trust.

Dr. Daniel Stein is a physician and healthcare executive with deep experience across clinical care, health policy, and corporate leadership. He is the founder and CEO of Embold Health, where he leads efforts to improve care quality through data-driven physician performance analytics. Previously, he served as Chief Medical Officer at Walmart Care Clinics and held policy roles with the U.S. Senate and CMS, bringing a unique blend of clinical insight and system-level strategy to healthcare reform.

Article written by MarketScale.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care Podcast

I Don't Care

Kevin Stevenson is the host of the healthcare podcast 'I Don't Care,' produced by MarketScale. He engages with healthcare executives, administrators, and innovators to explore the operational and technological challenges facing hospitals, urgent care centers, and telemedicine operators. Stevenson holds a doctorate and focuses on the people and solutions enabling better patient care delivery.

DS
Daniel Stein

Founder and CEO

Embold Health

Dr. Daniel Stein is an internal medicine physician and healthcare executive with experience spanning clinical care, health policy, and corporate leadership. He founded Embold Health, a platform that uses AI and data analytics to evaluate physician performance and guide patients to high-quality providers. He previously served as Chief Medical Officer at Walmart Care Clinics and held policy roles with the U.S. Senate and the Centers for Medicare & Medicaid Services.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512